- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06366295
Comparison of Subgingival Mechanotherapy With and Without the Use of a Perioscope: Clinical Trial
April 15, 2024 updated by: Medical University of Warsaw
Subgingival Mechanotherapy Using a Periodontal Endoscope Compared to Classical Subgingival Mechanotherapy for the Treatment of Periodontitis: a Randomized Clinical Trial
The study aims to comparatively assess clinical parameters, biochemical and microbiological parameters after treatment of periodontitis using subgingival mechanotherapy traditional and subgingival mechanotherapy using a perioscope.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Non-surgical treatment is the basic form of disease treatment periodontitis.
Its first stage is the mechanical removal of dental plaque along with the control of risk factors.
Subgingival mechanotherapy, also known as scaling and root planing (SRP) is the next stage, aimed at the subgingival area.
Perioscopy makes possible direct real-time visualization of the root surface during the procedure.
The research results published so far indicate improvement or no significant differences clinical parameters after SRP procedure using a perioscope vs traditional subgingival instrumentation.
The aim of this study is to indicate, or not, clinical, biochemical (level of pro-inflammatory cytokines) and microbiological (A.
actinomycetemcomitans, P. gingivalis, T. denticola) differences after periodontitis treatment using the traditional method vs. using a perioscope.
Study Type
Interventional
Enrollment (Estimated)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Karolina Grzywacka
- Phone Number: +48796137960
- Email: k.grzywacka@gmail.com
Study Contact Backup
- Name: Bartlomiej Górski, PhD
- Phone Number: +48 22 116 64 31
- Email: bartlomiej.gorski@wum.edu.pl
Study Locations
-
-
Mazowieckie
-
Warsaw, Mazowieckie, Poland, 02-097
- Recruiting
- Department of Periodontology and Oral Mucosa Diseases, Medical University of Warsaw
-
Contact:
- Bartlomiej Gorski, DDS, PhD
- Phone Number: +48 22 502 20 99
- Email: bartlomiej.gorski@wum.edu.pl
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age 20-60; (II)
- preserved lateral and anterior teeth;
- no periodontal treatment in the last 12 months;
- intermediate or advanced periodontitis (Stage II / III / IV)
- in each quadrant at least three teeth with PPD>5 mm after initial treatment (scaling, motivation, instruction)
Exclusion Criteria:
- antibiotic therapy in the last 6 months;
- smoking;
- systemic diseases affecting periodontal tissues;
- pregnancy or lactation;
- orthodontic treatment;
- tooth mobility II / III degree;
- involvement of third degree furcations according to Hamp classification;
- endodontic issues
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Subgingival mechanotherapy with perioscopy
Scaling and root planing using ultrasonic scaler and curettes, under the control of a perioscope, enabling real-time, magnified imaging of the root surface.
|
Subgingival mechanotherapy using a machine scaler, curettes and a perioscope
|
|
Active Comparator: Classical subgingival mechanotherapy
Scaling and root planing using ultrasonic scaler and curettes.
|
Subgingival mechanotherapy using a machine scaler and curettes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Probing pocket depth (PPD)
Time Frame: 0 (before), 3 and 6 months after SRP
|
Distance from the gingival margin to the bottom of the gingival sulcus
|
0 (before), 3 and 6 months after SRP
|
|
Clinical attachment level (CAL)
Time Frame: 0 (before), 3 and 6 months after SRP
|
Distance from the cementoenamel junction to the bottom of the gingival sulcus
|
0 (before), 3 and 6 months after SRP
|
|
Bleeding on probing (BoP)
Time Frame: 0 (before), 3 and 6 months after SRP
|
Percentage of sites with bleeding provoked by applying a probe to the bottom of a sulcus/pocket.
|
0 (before), 3 and 6 months after SRP
|
|
Plaque index (PI)
Time Frame: 0 (before), 3 and 6 months after SRP
|
Percentage of sites with plaque
|
0 (before), 3 and 6 months after SRP
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Width of keratinized tissue (KTW)
Time Frame: 0 (before), 3 and 6 months after SRP
|
Distance between the most apical point of gingival margin and the mucogingival junction
|
0 (before), 3 and 6 months after SRP
|
|
Gingival thickness (GT)
Time Frame: 0 (before), 3 and 6 months after SRP
|
Thickness of the gingiva measured 2 mm apical to the gingival margin
|
0 (before), 3 and 6 months after SRP
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subgingival plaque pathogens (Aa, Pg, Td) levels
Time Frame: 0 (before) and 6 months after SRP
|
Levels of periodontal pathogens (Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Treponema denticola) measured with real-time polymerase chain reaction (RT-PCR) test; data presented as number of bacteria of these species and percentage of total bacteria found in a sample; sample taken from the deepest pocket on each side.
|
0 (before) and 6 months after SRP
|
|
Gingival crevicular fluid levels of cytokines
Time Frame: 0 (before), 3 and 6 months after SRP
|
Levels of (IL - interleukin) IL-1β, IL-6, IL-8, IL-10 and interferon-gamma in gingival crevicular fluid presented as pg/ml; sample taken from the deepest pocket on each side.
|
0 (before), 3 and 6 months after SRP
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bartlomiej Górski, PhD, Department of Periodontology and Oral Mucosa Diseases, Medical University of Warsaw
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Estimated)
April 1, 2024
Study Completion (Estimated)
November 1, 2024
Study Registration Dates
First Submitted
April 10, 2024
First Submitted That Met QC Criteria
April 12, 2024
First Posted (Actual)
April 15, 2024
Study Record Updates
Last Update Posted (Actual)
April 17, 2024
Last Update Submitted That Met QC Criteria
April 15, 2024
Last Verified
June 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- WUM.Perio.05
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis
-
Mahsa UniversityRecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage IIIMalaysia
-
Shanghai Ninth People's Hospital Affiliated to...Not yet recruitingPeriodontitis Stage II | Periodontitis Stage III | Periodontitis Stage IV
-
Misr University for Science and TechnologyCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Cairo UniversityRecruitingPeriodontitis | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Ataturk UniversityCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage IITurkey (Türkiye)
-
Al-Azhar UniversityNot yet recruitingStage IV Periodontitis | Advanced Periodontitis | Stage III PeriodontitisEgypt
-
Azienda Socio Sanitaria Territoriale degli Spedali...Università degli Studi di FerraraCompletedPeriodontitis, Aggressive | Periodontitis, AdultItaly
-
University Hospital HeidelbergRecruitingPeriodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Stage IVGermany
-
Akdeniz UniversityNot yet recruitingPeriodontitis (Stage 3) | Periodontitis Stage IVTurkey (Türkiye)
-
Gülnur EmingilEge University Scientific Research Projects Coordination UnitCompletedPeriodontitis (Stage 3) | Periodontitis Stage IIITurkey (Türkiye)
Clinical Trials on subgingival mechanotherapy with perioscopy
-
Moscow Scientific and Practical Center of Medical...RecruitingIschemic Stroke, AcuteRussian Federation
-
Yasmeen KhaledCompleted
-
Queen Mary University of LondonCompletedChronic PeriodontitisUnited Kingdom
-
Sarah Al-RihaymeeEnrolling by invitationPeriodontitis | Periodontal HealthIraq
-
University of ZurichCompleted
-
Ataturk UniversityCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage IITurkey (Türkiye)
-
University of Sao PauloRecruitingPeriodontitis | Type 2 Diabetes | HalitosisBrazil
-
National Institutes of Health Clinical Center (CC)Bristol-Myers Squibb; National Institute of Allergy and Infectious Diseases...Completed
-
Lithuanian University of Health SciencesCompleted
-
University of Roma La SapienzaCompleted